SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
Pfizer slashes 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales - CNBC
5/3/22 at 10:59am
Organization
CNBC
Author
Spencer Kimball
35 words
0
Comments
Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.
You are the first to view
https://www.cnbc.com/2022/05/03/covid-pfizer-pfe-earnings-q1-2022-.html
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...